Gofen & Glossberg LLC IL Has $5.26 Million Position in Becton, Dickinson and Company (BDX)

Gofen & Glossberg LLC IL increased its holdings in Becton, Dickinson and Company (NYSE:BDX) by 124.9% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 26,944 shares of the medical instruments supplier’s stock after purchasing an additional 14,964 shares during the quarter. Gofen & Glossberg LLC IL’s holdings in Becton, Dickinson and were worth $5,257,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Waldron LP bought a new stake in Becton, Dickinson and during the first quarter valued at $383,000. Northwestern Mutual Investment Management Company LLC boosted its position in Becton, Dickinson and by 76.5% during the first quarter. Northwestern Mutual Investment Management Company LLC now owns 43,021 shares of the medical instruments supplier’s stock valued at $7,892,000 after acquiring an additional 18,641 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Becton, Dickinson and by 6.2% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 46,105 shares of the medical instruments supplier’s stock valued at $8,457,000 after acquiring an additional 2,672 shares during the last quarter. South State Corp boosted its position in Becton, Dickinson and by 10.3% during the first quarter. South State Corp now owns 1,610 shares of the medical instruments supplier’s stock valued at $296,000 after acquiring an additional 150 shares during the last quarter. Finally, Oxford Asset Management bought a new stake in Becton, Dickinson and during the first quarter valued at $6,820,000. 86.83% of the stock is currently owned by institutional investors.

In related news, insider Gary M. Cohen sold 15,512 shares of Becton, Dickinson and stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $203.77, for a total transaction of $3,160,880.24. Following the completion of the transaction, the insider now directly owns 95,781 shares of the company’s stock, valued at approximately $19,517,294.37. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Thomas E. Polen, Jr. sold 5,971 shares of Becton, Dickinson and stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $197.41, for a total transaction of $1,178,735.11. Following the transaction, the insider now directly owns 12,861 shares of the company’s stock, valued at $2,538,890.01. The disclosure for this sale can be found here. Over the last three months, insiders have sold 75,904 shares of company stock valued at $15,242,688. 1.40% of the stock is currently owned by corporate insiders.

COPYRIGHT VIOLATION WARNING: “Gofen & Glossberg LLC IL Has $5.26 Million Position in Becton, Dickinson and Company (BDX)” was posted by Community Financial News and is owned by of Community Financial News. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.com-unik.info/2017/10/29/gofen-glossberg-llc-il-has-5-26-million-position-in-becton-dickinson-and-company-bdx.html.

A number of brokerages have commented on BDX. Barclays PLC reaffirmed an “equal weight” rating and set a $210.00 price target (up previously from $205.00) on shares of Becton, Dickinson and in a research report on Thursday, August 10th. BidaskClub cut shares of Becton, Dickinson and from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Zacks Investment Research raised shares of Becton, Dickinson and from a “sell” rating to a “hold” rating in a research report on Friday, October 20th. Piper Jaffray Companies reaffirmed a “buy” rating and set a $213.00 price target on shares of Becton, Dickinson and in a research report on Tuesday, September 12th. Finally, Stifel Nicolaus reaffirmed a “buy” rating on shares of Becton, Dickinson and in a research report on Wednesday, August 9th. Five research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $205.14.

Shares of Becton, Dickinson and Company (BDX) opened at 210.10 on Friday. The firm has a market cap of $47.81 billion, a price-to-earnings ratio of 60.85 and a beta of 1.05. The company has a 50 day moving average of $199.84 and a 200-day moving average of $194.77. Becton, Dickinson and Company has a 12-month low of $161.29 and a 12-month high of $214.72.

Becton, Dickinson and (NYSE:BDX) last issued its quarterly earnings results on Thursday, August 3rd. The medical instruments supplier reported $2.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.44 by $0.02. Becton, Dickinson and had a net margin of 6.25% and a return on equity of 22.53%. The company had revenue of $3.04 billion during the quarter, compared to analysts’ expectations of $3.06 billion. During the same period last year, the company posted $2.35 EPS. Becton, Dickinson and’s revenue was down 5.1% on a year-over-year basis. Analysts predict that Becton, Dickinson and Company will post $9.46 EPS for the current year.

About Becton, Dickinson and

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

What are top analysts saying about Becton Dickinson and Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Becton Dickinson and Company and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit